• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Co-Executive Chairman Kravis Henry R sold $153,755,831 worth of shares (1,281,394 units at $119.99), decreasing direct ownership by 2% to 73,006,022 units (SEC Form 4)

    6/2/25 9:10:22 PM ET
    $KKR
    Investment Managers
    Finance
    Get the next $KKR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    KRAVIS HENRY R

    (Last) (First) (Middle)
    C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
    30 HUDSON YARDS

    (Street)
    NEW YORK NY 10001

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    KKR & Co. Inc. [ KKR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Co-Executive Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    06/02/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/02/2025 S 1,150,469 D $119.8 73,006,022 D
    Common Stock 06/02/2025 S 130,925 D $121.67(1) 0 I See Footnote(2)
    Common Stock 1,549,369 I See Footnote(3)
    Common Stock 1,000,000 I See Footnote(4)
    Common Stock 5,810,000 I See Footnote(5)
    Common Stock 15,227 I See Footnote(6)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.35 to $121.9323, inclusive. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
    2. These shares of common stock are held by a limited liability company of which the Reporting Person is the managing member.
    3. These shares are held by a limited partnership, whose general partner is a limited liability company, over which the Reporting Person has investment discretion.
    4. These shares are held by a grantor retained annuity trust.
    5. These shares of common stock are held by a limited partnership (the "Partnership"), which is an entity controlled by the Reporting Person. As previously reported on a Form 4 filed on May 18, 2018, these shares of common stock are being held by the Partnership solely for purposes of future charitable donations.
    6. These shares of common stock are held by the Reporting Person's spouse.
    Remarks:
    Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, the Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. In addition to the shares covered by this filing, Mr. Kravis may sell up to an additional 1.5 million shares of common stock of the Issuer during calendar year 2025. Mr. Kravis currently intends to use the proceeds from these sales to fund personal investments and expenses and/or for charitable purposes. As of the date of this filing, except as disclosed herein, Mr. Kravis has no present plan to sell any additional shares.
    /s/ Christopher Lee, Attorney-in-fact 06/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $KKR alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $KKR

    DatePrice TargetRatingAnalyst
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    6/30/2025$150.00Overweight
    Piper Sandler
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    3/20/2025$150.00 → $141.00Equal Weight → Overweight
    Wells Fargo
    1/30/2025$173.00Buy → Hold
    HSBC Securities
    9/18/2024$148.00Buy
    HSBC Securities
    More analyst ratings

    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm's Health Care Franchise and Enhancing its Life Sciences Strategy

      KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company. This strategic partnership will enable KKR to enhance its capabilities in biopharma royalty and credit investing, while expanding the firm's existing footprint in the life sciences ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730161531/en/ Founded in 2006 and headquartered in Stamford, Connecticut, HCRx has a strong track record of investing in commercial-stage and near-commercial-stage biopharmaceutical assets. Si

      7/30/25 9:00:00 AM ET
      $KKR
      Investment Managers
      Finance
    • Harley-Davidson Announces Strategic Partnership with KKR and PIMCO

      Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea

      7/30/25 7:00:00 AM ET
      $HOG
      $KKR
      Motor Vehicles
      Consumer Discretionary
      Investment Managers
      Finance
    • Capital Group Files for First Public-Private Equity Fund, Furthering Exclusive Strategic Partnership with KKR

      Capital Group KKR U.S. Equity+ expected to launch in the U.S. in early 2026, blending public and private equity investing and adding to suite of solutions built for everyday investors, pending regulatory approval LOS ANGELES and NEW YORK, July 30, 2025 /PRNewswire/ -- Leading global investment firms Capital Group and KKR take the next step in their partnership to increase access to private markets with Capital Group's proposed offering of a new public-private equity interval fund. Building on the April launch of the firms' first two public-private credit interval funds, Capita

      7/30/25 7:00:00 AM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Kkr Alternative Assets Llc acquired $2,901,156 worth of Class I Common Stock (121,083 units at $23.96) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      7/2/25 4:05:44 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 4 filed by Large owner Kkr Group Partnership L.P.

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/18/25 7:26:27 PM ET
      $KKR
      Investment Managers
      Finance
    • Large owner Kkr Alternative Assets Llc acquired $1,328,447 worth of Class I Common Stock (55,537 units at $23.92) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/3/25 4:25:14 PM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    SEC Filings

    See more
    • KKR & Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - KKR & Co. Inc. (0001404912) (Filer)

      6/23/25 5:00:48 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 144 filed by KKR & Co. Inc.

      144 - KKR & Co. Inc. (0001404912) (Subject)

      6/2/25 9:18:45 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 144 filed by KKR & Co. Inc.

      144 - KKR & Co. Inc. (0001404912) (Subject)

      6/2/25 9:13:28 PM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KKR downgraded by Citizens JMP

      Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform

      7/14/25 8:40:54 AM ET
      $KKR
      Investment Managers
      Finance
    • KKR downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00

      7/9/25 10:14:31 AM ET
      $KKR
      Investment Managers
      Finance
    • Piper Sandler initiated coverage on KKR with a new price target

      Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00

      6/30/25 8:01:12 AM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Barakett Timothy R bought $4,127,319 worth of shares (35,000 units at $117.92) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Issuer)

      5/27/25 8:01:38 PM ET
      $KKR
      Investment Managers
      Finance
    • Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Issuer)

      5/8/25 7:01:53 PM ET
      $KKR
      Investment Managers
      Finance
    • Kkr Alternative Assets Llc bought $50,000,000 worth of Class I Common Stock (1,956,182 units at $25.56) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/6/24 9:02:29 PM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    Leadership Updates

    Live Leadership Updates

    See more
    • Harley-Davidson Announces Strategic Partnership with KKR and PIMCO

      Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea

      7/30/25 7:00:00 AM ET
      $HOG
      $KKR
      Motor Vehicles
      Consumer Discretionary
      Investment Managers
      Finance
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance
    • KKR Appoints Timothy R. Barakett to Board

      KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket

      3/13/25 4:30:00 PM ET
      $KKR
      Investment Managers
      Finance

    $KKR
    Financials

    Live finance-specific insights

    See more
    • KKR & Co. Inc. to Announce Second Quarter 2025 Results

      KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be a

      7/14/25 4:15:00 PM ET
      $KKR
      Investment Managers
      Finance
    • Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million

      Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfront Cash and Up to €27 Million in Potential Future Milestone Payments Expected Net Proceeds to be Directed Towards Previously Announced Capital Allocation Priorities, Including Further Strengthening the Company's Balance Sheet DUBLIN, July 14, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading global provider of Consumer Self-Care Products, today announced it has signed an agreement with Kairos Bidco AB, an investment vehicle managed by KKR, a leading glo

      7/14/25 8:30:00 AM ET
      $KKR
      $PRGO
      Investment Managers
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FSK Announces Earnings Release and Conference Call Schedule for Second Quarter 2025

      PHILADELPHIA and NEW YORK, July 10, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its second quarter 2025 results after the close of trading on the New York Stock Exchange on Wednesday, August 6, 2025. FSK will host its second quarter 2025 results conference call via live webcast on Thursday, August 7, 2025 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the Investor Relations section of FSK's website at www.fskkradvisor.com under Events or through the following URL: htt

      7/10/25 4:15:00 PM ET
      $FSK
      $KKR
      Investment Managers
      Finance

    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

      SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

      11/12/24 3:50:17 PM ET
      $KKR
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

      SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

      11/4/24 11:48:27 AM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form SC 13G/A filed by KKR & Co. Inc. (Amendment)

      SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

      2/13/24 6:32:37 PM ET
      $KKR
      Investment Managers
      Finance